Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 27, 2022 4:05 P.M.
Form: F-1
CIK: 0001601936
Company Name: Altamira Therapeutics Ltd.
File Number: 333-268838